APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer-Reference-Cited by-同舟云学术

APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer

Published:2019-07 Issue:1 Volume:76 Page:9-13
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Shi Ming-Jun,Meng Xiang-Yu,Lamy Philippe,Banday A. Rouf,Yang Jie,Moreno-Vega Aura,Chen Chun-Long,Dyrskjøt Lars,Bernard-Pierrot Isabelle,Prokunina-Olsson Ludmila,Radvanyi François

Funder

Institut National de la Santé et de la Recherche Médicale

China Scholarship Council

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. Comprehensive transcriptional analysis of early-stage urothelial carcinoma;Hedegaard;Cancer Cell,2016

2. Comprehensive molecular characterization of muscle-invasive bladder cancer;Robertson;Cell,2017

3. The repertoire of mutational signatures in human cancer;Alexandrov;BioRxiv,2018

4. Paired exome analysis reveals clonal evolution and potential therapeutic targets in urothelial carcinoma;Lamy;Cancer Res,2016

5. Mutational strand asymmetries in cancer genomes reveal mechanisms of DNA damage and repair;Haradhvala;Cell,2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies;Cancer Communications;2024-08-19

2. Photodynamic Diagnosis and Therapy in Non-Muscle-Invasive Bladder Cancer;Cancers;2024-06-22

3. Transcriptomic Profiling of Upper Tract Urothelial Carcinoma: Bladder Cancer Consensus Classification Relevance, Molecular Heterogeneity, and Differential Immune Signatures;Modern Pathology;2023-11

4. Bladder cancer;Nature Reviews Disease Primers;2023-10-26

5. Historical Pathogen-Driven Selection May Contribute to Contemporary Ethnic Difference in Bladder Cancer Susceptibility;Bladder Cancer;2023-09-25